Why WTO should suspend intellectual property protection for Covid-19 Vaccines

Covid-19 vaccine

A medical health worker fills a syringe with the Covid-19 vaccine at Clalit Health Services center in Tel Aviv on December 21, 2020.

Photo credit: Gil Cohen-Magen | AFP

Behind the great and calming news of Covid-19 vaccine, there is a raging battle between the rich and poor countries over the intellectual property (IP) which is being seen as a barrier to development or distribution of Covid vaccines and treatments.

Welcome!

You're all set to enjoy unlimited Prime content.